Stock listing

NASDAQ:AMIX Autonomix Medical, Inc. Stock

Home listing (NASDAQ) of Autonomix Medical, Inc.

Follow Autonomix Medical, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:AMIX

$0.891 USD -0.199 (-18.2%)

Close on Nov 20, 2026

Past year -95.7% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.880 – $1.040 USDNov 20, 2026
Volume
219,017 sharesNov 20, 2026
Market cap
$1.82M USDAt the close on Nov 20, 2026 · price × 2.05M shares outstanding
52-week range
$0.880 – $24.680 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$7.19M USDMedian day 85,400 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Autonomix Medical, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:AMIX · Home$0.891 USD-0.199 (-18.2%)219,017$1.040$1.040$0.880$1.090Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:AMIX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.891-0.199-18.2%$1.040$1.040$0.880219,017
$1.090+0.010+0.9%$1.080$1.150$1.080105,810
$1.080-0.020-1.8%$1.070$1.220$1.060114,129
$1.100-0.270-19.7%$1.330$1.410$0.932546,287
$1.370+0.015+1.1%$1.340$1.489$1.330200,562
$1.355-0.125-8.4%$1.440$1.440$1.305489,042
$1.480-0.370-20.0%$1.650$1.670$1.4201,317,813
$1.850+0.150+8.8%$1.810$3.300$1.62072,180,709
$1.700+0.180+11.8%$1.565$1.770$1.530342,888
$1.5200.0000.0%$1.510$1.680$1.46085,900
$1.520-0.090-5.6%$1.660$1.670$1.52065,200
$1.610-0.050-3.0%$1.730$1.780$1.61081,200
$1.660-0.020-1.2%$1.710$1.730$1.63443,000
$1.680-0.130-7.2%$1.850$1.880$1.68051,400
$1.810-0.230-11.3%$2.080$2.150$1.810134,500
$2.040-0.110-5.1%$2.110$2.219$2.04053,800
$2.150+0.080+3.9%$2.160$2.165$2.11029,700
$2.070-0.030-1.4%$2.080$2.139$2.06036,900
$2.100-0.320-13.2%$2.340$2.436$2.050158,300
$2.420-0.080-3.2%$2.500$2.500$2.41560,200
$2.500-0.070-2.7%$2.640$2.640$2.50028,000
$2.570-0.040-1.5%$2.610$2.700$2.56015,000
$2.610-0.040-1.5%$2.690$2.690$2.60027,000
$2.650-0.195-6.9%$2.900$2.900$2.63037,900
$2.845-0.085-2.9%$2.930$3.000$2.80031,200
$2.930+0.030+1.0%$2.890$2.960$2.81031,800
$2.900-0.110-3.7%$3.030$3.070$2.90056,400
$3.010-0.090-2.9%$3.090$3.165$3.00030,800
$3.100-0.010-0.3%$3.130$3.190$3.10041,900
$3.110-0.020-0.6%$3.100$3.170$3.08033,100
$3.130-0.280-8.2%$3.400$3.400$3.10087,100
$3.410-0.060-1.7%$3.490$3.590$3.39056,200
$3.470-0.070-2.0%$3.540$3.600$3.45063,300
$3.540-0.240-6.3%$3.680$3.730$3.540133,300
$3.780-0.140-3.6%$3.990$4.040$3.6202,574,700
$3.920+0.090+2.3%$3.840$4.200$3.795133,300
$3.830+0.080+2.1%$3.830$3.910$3.600401,800
$3.750-0.080-2.1%$3.865$3.885$3.73047,500
$3.830-0.190-4.7%$3.800$3.942$3.77374,200
$4.020-0.050-1.2%$4.095$4.300$3.910262,800
$4.070+0.090+2.3%$4.050$4.180$3.94047,900
$3.980-0.150-3.6%$4.110$4.110$3.90055,200
$4.130+0.080+2.0%$4.000$4.220$4.00060,900
$4.050-0.160-3.8%$4.130$4.290$3.91083,800
$4.210-0.070-1.6%$4.390$4.390$4.18032,200
$4.280+0.160+3.9%$4.050$4.380$4.05067,200
$4.120-0.090-2.1%$4.000$4.220$3.910151,200
$4.210-0.120-2.8%$4.260$4.450$4.130127,500
$4.330-0.040-0.9%$4.300$4.420$4.23052,300
$4.370-0.015-0.3%$4.390$4.520$4.30254,000
$4.385-0.185-4.0%$4.480$4.510$4.32085,400
$4.570-0.010-0.2%$4.600$4.666$4.40087,100
$4.580-0.010-0.2%$4.470$4.750$4.47078,500
$4.590-0.090-1.9%$4.590$4.680$4.44466,000
$4.680+0.180+4.0%$4.475$4.810$4.310193,300
$4.500-0.240-5.1%$4.650$4.681$4.390100,800
$4.740-0.090-1.9%$4.670$4.800$4.530125,900
$4.830-0.490-9.2%$5.200$5.200$4.660360,400
$5.320-0.310-5.5%$5.370$5.610$5.080312,200
$5.630-0.750-11.8%$6.210$6.290$5.620362,900
$6.380-0.810-11.3%$6.830$7.300$6.3111,438,900
$7.190+1.820+33.9%$7.610$9.990$7.14528,618,100
$5.370+0.100+1.9%$5.240$5.590$4.97015,602,000
$5.2700.0000.0%$5.190$5.870$5.190109,100
$5.270-0.640-10.8%$5.790$5.970$5.140177,000

Splits

2 splits since 2024 · NASDAQ:AMIX · every price before a split is adjusted for it

DayRatioWhat
1-for-21Consolidation
1-for-20Consolidation
Ticker
NASDAQ:AMIX
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Autonomix Medical, Inc. news

Autonomix Medical, Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
35 in the last 12 months · 109 in all · newest Nov 12, 2026 · oldest 2024
Decks
7 decks · latest Nov 20, 2026

Where Autonomix Medical, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:AMIX · Home listing · This pageNASDAQUnited StatesUSD
BOATS:AMIXBOATSUnited StatesUSD

Valuation

Price/book 0.3× against a median of 0.3×: 4th lowest of 9 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
−$5.87M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
0.3×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
1.79

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Autonomix Medical, Inc. · NASDAQ:AMIXUS$1.82M−US$5.87Mn/an/an/a0.3×n/a0.0×1.79
LKL International Bhd. · MYX:LKLUS$2.36MUS$4.15Mn/a0.3×n/a0.1×−46.9%0.2×n/a
RemSleep Holdings, Inc. · OTC:RMSLUS$2.09MUS$2.06Mn/a123×n/an/an/an/a-0.01
Fuse Medical, Inc. · OTC:FZMDUS$2.03MUS$4.31M14.8×0.5×7.8×0.3×1.5%0.4×0.54
Nuwellis, Inc. · NASDAQ:NUWEUS$1.84M−US$6.31Mn/a−0.7×n/a0.2×−152.8%0.0×2.26
Vivos Therapeutics, Inc. · NASDAQ:VVOSUS$1.83MUS$2.11Mn/a0.1×n/a0.8×−107.1%0.2×1.41
Adagio Medical Holdings, Inc · NASDAQ:ADGMUS$1.72MUS$636,0102.1×n/an/a0.1×n/a0.1×0.69
Escalon Medical Corp. · OTC:ESMCUS$1.71M−US$1.96M0.4×−0.1×n/a0.3×32.8%0.0×-0.06
Therma Bright Inc. · TSXV:THRMUS$1.66MUS$1.64Mn/a17.3×n/an/an/an/a-0.15
Nexalin Technology, Inc. · NASDAQ:NXLUS$1.45MUS$1.88Mn/a6.8×n/a5.5×n/a4.7×0.52
Zero Candida Technologies Inc. · TSXV:ZCTUS$1.43M−US$59,292n/an/an/a2.2×n/a0.0×-0.17
Median of the othersUS$1.77MUS$1.76M2.1×0.4×7.8×0.3×−46.9%0.1×0.52

Forecasts

1 strong buy · 1 buy · Analysts' consensus from EODHD, read Nov 12, 2026. Not 6ix's view and not investment advice.

Price target
40.80 USD · Analysts' mean
EPS, year to Mar 2027
-8.60 · 1 analyst

Team and board

Officers

OfficerRole
Brad HauserPresident and Chief Executive Officer
Trent SmithChief Financial Officer
Jennifer CookChief Business Officer
Robert SchwartzChief Medical Officer
Walter V. KlempExecutive Chairman

Board

DirectorRole
Walter V. KlempExecutive Chairman
Christopher CapelliDirector
David RobinsDirector
Jonathan P. FosterDirector
Lori BissonExecutive Vice Chairman
Sandra Cohen KalterDirector

Events

QuarterResultsShare move
Q2 2027Nov 10, 2026 · Before open+8.8%
Q1 2027Aug 12, 2026−24.8%
Q4 2026Jun 3, 2026−1.2%
Q3 2026Feb 11, 2026 · After close−1.8%
Q2 2026Nov 12, 2025 · After close−13.8%
Q1 2026Aug 13, 2025 · After close+1.8%
Q4 2025May 29, 2025 · After close−2.7%
Q3 2025Feb 13, 2025 · Before open+4.8%
Q2 2025Nov 8, 2024 · After close−4.7%
Q1 2025Aug 28, 2024−2.5%
All 11 quarters
QuarterResultsShare move
Q4 2024May 29, 2024+2.9%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (November 2026)Investor deck17 slidesNov 20, 2026
Investor Presentation (January 2026)Investor deck17 slidesJan 9, 2026
Investor Presentation (April 2025)Investor deck18 slidesApr 30, 2025
Investor Presentation (January 2025)Investor deck18 slidesJan 22, 2025
Corporate Update (June 2024)Corporate update13 slidesJun 18, 2024
Investor Presentation (March 2024)Investor deck23 slidesMar 4, 2024
Reset Pharma — Investor Presentation (August 2023)Investor deck36 slidesAugust 2023

Open Decks

Financings

RaiseDate
Common stock issued on exercise of July 2026 warrants, with new unregistered Series E-1 and E-2 warrants
Announced: about US$4.9M · US$5.75 a share · Warrants at US$6.25 for 60 months · Maxim Group LLC
Dealers: Maxim Group LLC (lead)
Aug 25, 2026
Common stock issued on exercise of November 2025 warrants
Announced: about US$2.6M · US$6 a share · ½ warrant at US$5.75 for 66 months · Maxim Group LLC
Dealers: Maxim Group LLC (lead)
Jul 14, 2026
Private placement of shares of common stock (or pre-funded warrants) and Series C warrants
Announced: about US$5M · US$1.1107 a share · ½ warrant at US$0.8607 for 66 months · Maxim Group LLC
Dealers: Maxim Group LLC (lead)
Nov 18, 2025
Warrant exercise of shares of common stock upon exercise of existing warrants
Announced: about US$2.5M · US$1.723 a share · ½ warrant at US$1.723 for 66 months · Ladenburg Thalmann & Co. Inc.
Dealers: Ladenburg Thalmann & Co. Inc. (lead)
Use of proceeds: Working capital and general corporate purposes
Jul 22, 2025
Public offering of common stock units and pre-funded warrant units
Closed: US$10M raised · US$6.54 a unit · 1 warrant at US$6.54 for 60 months · Ladenburg Thalmann & Co. Inc.
Dealers: Ladenburg Thalmann & Co. Inc. (lead)
Use of proceeds: Fund its clinical trial, other research and development, development of intellectual property, and working capital
Nov 25, 2024

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2026FY2025FY2024FY2023FY2022
Revenue0000
Cost of revenue12.0K183.0K81.0K
Gross profit-12.0K-183.0K-81.0K
Research and development7.14M4.72M2.23M745.0K4.07K
Selling, general and administrative9.89M6.86M5.25M1.25M13.6M
Operating income-17.0M-11.6M-12.0M-1.99M-13.6M
Depreciation and amortization12.0K183.0K81.0K013.6M
EBITDA-17.0M-11.4M-11.9M-1.99M0
Interest expense0176.0K79.0K0218.1K
Income before tax-16.7M-11.4M-15.4M-1.99M-13.3M
Income tax0000-13.6M
Net income-16.7M-11.4M-15.4M-1.99M-13.3M
Earnings per share, basic-2.32-6.46-14.82-0.17-297.87

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022
Cash and equivalents7.00M9.14M8.61M865.0K2.04M
Current assets7.58M9.61M9.39M865.0K2.05M
Property, plant and equipment19.0K21.0K16.0K0
Total assets7.60M9.81M9.41M865.0K2.05M
Accounts payable700.0K676.0K492.0K173.0K91.6K
Current liabilities1.71M1.71M777.0K221.0K93.2K
Long-term debt1.00M
Total debt1.00M0
Total liabilities1.71M1.71M1.78M221.0K93.2K
Shareholders' equity5.89M8.10M7.63M644.0K1.96M
Shares outstanding542.3K2.50M942.6K12.3M44.7K

Cash flow

LineFY2026FY2025FY2024FY2023FY2022
Cash from operations-12.3M-8.26M-6.60M-1.85M-387.3K
Capital spending-10.0K-14.0K-19.0K0-3
Free cash flow-12.3M-8.27M-6.62M-1.85M-387.3K
Cash from investing-10.0K-14.0K-19.0K0
Cash from financing10.2M8.80M14.4M675.0K2.43M
Change in cash-2.13M528.0K7.74M-1.18M2.04M

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportNov 20, 2026Current reportSEC
10-Q · Quarterly reportNov 10, 2026Quarterly reportSEC
8-K · Current reportNov 3, 2026Management or board changeSEC
3 · Initial statement of ownershipOct 13, 2026Insider tradeSEC
4 · Change in ownershipSep 21, 2026Insider tradeSEC
424B3 · ProspectusSep 16, 2026Offer documentSEC
8-K · Current reportSep 16, 2026Management or board changeSEC
EFFECT · Notice that a registration is effectiveSep 16, 2026Other filingsSEC
DEFA14A · Additional proxy materialSep 14, 2026Meeting noticeSEC
DEF 14A · Proxy statementSep 14, 2026Meeting noticeSEC
All 151 filings
FilingDateTypeFiled with
424B5 · ProspectusSep 11, 2026Offer documentSEC
4 · Change in ownershipSep 8, 2026Insider tradeSEC
4 · Change in ownershipSep 8, 2026Insider tradeSEC
4 · Change in ownershipSep 8, 2026Insider tradeSEC
PRE 14A · Preliminary proxy statementSep 4, 2026Meeting noticeSEC
S-3 · Registration statementSep 4, 2026Offer documentSEC
8-K · Current reportAug 26, 2026Material contractSEC
10-Q · Quarterly reportAug 12, 2026Quarterly reportSEC
EFFECT · Notice that a registration is effectiveAug 5, 2026Other filingsSEC
424B5 · ProspectusJul 31, 2026Offer documentSEC
S-3 · Registration statementJul 28, 2026Offer documentSEC
8-K · Current reportJul 28, 2026Current reportSEC
8-K · Current reportJul 15, 2026Material contractSEC
8-K · Current reportJul 10, 2026Current reportSEC
8-K · Current reportJun 24, 2026Current reportSEC
10-K/A · Annual report, amendedJun 15, 2026Annual reportSEC
10-K · Annual reportMay 27, 2026Annual reportSEC
S-8 · Registration statement for employee plansApr 2, 2026Offer documentSEC
10-Q · Quarterly reportFeb 11, 2026Quarterly reportSEC
8-K · Current reportJan 16, 2026Current reportSEC
8-K · Current reportJan 9, 2026Current reportSEC
424B3 · ProspectusDec 12, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveDec 12, 2025Other filingsSEC
CORRESP · Letter to the SECDec 9, 2025Other filingsSEC
S-3 · Registration statementNov 26, 2025Offer documentSEC
8-K · Current reportNov 19, 2025Material contractSEC
10-Q · Quarterly reportNov 12, 2025Quarterly reportSEC
8-K · Current reportNov 3, 2025Meeting outcomeSEC
424B3 · ProspectusOct 6, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveOct 1, 2025Other filingsSEC
CORRESP · Letter to the SECSep 29, 2025Other filingsSEC
UPLOAD · Letter from the SECSep 29, 2025Other filingsSEC
S-1 · Registration statementSep 23, 2025Offer documentSEC
DEFA14A · Additional proxy materialSep 12, 2025Meeting noticeSEC
DEF 14A · Proxy statementSep 12, 2025Meeting noticeSEC
424B3 · ProspectusSep 11, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveSep 9, 2025Other filingsSEC
CORRESP · Letter to the SECSep 4, 2025Other filingsSEC
S-1/A · Registration statement, amendedSep 3, 2025Offer documentSEC
PRE 14A · Preliminary proxy statementAug 29, 2025Meeting noticeSEC
UPLOAD · Letter from the SECAug 28, 2025Other filingsSEC
8-K · Current reportAug 27, 2025Current reportSEC
8-K · Current reportAug 26, 2025Material contractSEC
424B5 · ProspectusAug 25, 2025Offer documentSEC
S-1 · Registration statementAug 20, 2025Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
4 · Change in ownershipAug 13, 2025Insider tradeSEC
4 · Change in ownershipAug 13, 2025Insider tradeSEC
4 · Change in ownershipAug 13, 2025Insider tradeSEC
4 · Change in ownershipAug 13, 2025Insider tradeSEC
4 · Change in ownershipAug 13, 2025Insider tradeSEC
10-Q · Quarterly reportAug 13, 2025Quarterly reportSEC
10-K/A · Annual report, amendedJul 28, 2025Annual reportSEC
424B3 · ProspectusJul 22, 2025Offer documentSEC
8-K · Current reportJul 22, 2025Material contractSEC
EFFECT · Notice that a registration is effectiveJul 14, 2025Other filingsSEC
POS AM · Amendment to an effective registrationJul 3, 2025Offer documentSEC
10-K · Annual reportMay 29, 2025Annual reportSEC
8-K · Current reportApr 30, 2025Current reportSEC
EFFECT · Notice that a registration is effectiveMar 12, 2025Other filingsSEC
CORRESP · Letter to the SECMar 10, 2025Other filingsSEC
S-3/A · Registration statement, amendedMar 7, 2025Offer documentSEC
UPLOAD · Letter from the SECMar 7, 2025Other filingsSEC
S-3 · Registration statementFeb 28, 2025Offer documentSEC
8-K · Current reportFeb 28, 2025Material contractSEC
8-K · Current reportFeb 13, 2025ResultsSEC
10-Q · Quarterly reportFeb 13, 2025Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 7, 2025Big-stake noticeSEC
8-K · Current reportJan 22, 2025Current reportSEC
SC 13G · Big-stake noticeDec 3, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeNov 27, 2024Big-stake noticeSEC
8-K · Current reportNov 25, 2024Material contractSEC
424B4 · ProspectusNov 25, 2024Offer documentSEC
EFFECT · Notice that a registration is effectiveNov 25, 2024Other filingsSEC
CORRESP · Letter to the SECNov 19, 2024Other filingsSEC
CORRESP · Letter to the SECNov 19, 2024Other filingsSEC
S-1/A · Registration statement, amendedNov 12, 2024Offer documentSEC
8-K · Current reportNov 12, 2024ResultsSEC
10-Q · Quarterly reportNov 8, 2024Quarterly reportSEC
8-K · Current reportNov 4, 2024Current reportSEC
S-1 · Registration statementNov 1, 2024Offer documentSEC
8-K · Current reportOct 28, 2024Current reportSEC
8-K · Current reportOct 17, 2024Meeting outcomeSEC
SC 13G · Big-stake noticeOct 7, 2024Big-stake noticeSEC
8-K · Current reportSep 20, 2024Current reportSEC
DEFA14A · Additional proxy materialSep 4, 2024Meeting noticeSEC
DEF 14A · Proxy statementSep 4, 2024Meeting noticeSEC
PRE 14A · Preliminary proxy statementAug 23, 2024Meeting noticeSEC
10-Q · Quarterly reportAug 13, 2024Quarterly reportSEC
8-K · Current reportAug 13, 2024ResultsSEC
UPLOAD · Letter from the SECAug 2, 2024Other filingsSEC
10-K/A · Annual report, amendedJul 26, 2024Annual reportSEC
4 · Change in ownershipJul 26, 2024Insider tradeSEC
DRS · Draft registration statementJul 25, 2024Offer documentSEC
8-K · Current reportJul 15, 2024Material contractSEC
4 · Change in ownershipJun 24, 2024Insider tradeSEC
4 · Change in ownershipJun 24, 2024Insider tradeSEC
4 · Change in ownershipJun 24, 2024Insider tradeSEC
8-K · Current reportJun 21, 2024Management or board changeSEC
4 · Change in ownershipJun 20, 2024Insider tradeSEC
3 · Initial statement of ownershipJun 20, 2024Insider tradeSEC
4 · Change in ownershipJun 20, 2024Insider tradeSEC
8-K · Current reportJun 18, 2024Current reportSEC
8-K · Current reportJun 17, 2024Management or board changeSEC
S-8 · Registration statement for employee plansMay 31, 2024Offer documentSEC
10-K · Annual reportMay 31, 2024Annual reportSEC
8-K · Current reportMay 31, 2024ResultsSEC
8-K · Current reportMar 4, 2024Current reportSEC
SC 13D · Big-stake noticeFeb 26, 2024Big-stake noticeSEC
SC 13D · Big-stake noticeFeb 15, 2024Big-stake noticeSEC
10-Q · Quarterly reportFeb 13, 2024Quarterly reportSEC
3 · Initial statement of ownershipFeb 1, 2024Insider tradeSEC
8-K · Current reportJan 31, 2024FinancingSEC
3 · Initial statement of ownershipJan 26, 2024Insider tradeSEC
3 · Initial statement of ownershipJan 26, 2024Insider tradeSEC
3 · Initial statement of ownershipJan 26, 2024Insider tradeSEC
3 · Initial statement of ownershipJan 26, 2024Insider tradeSEC
3 · Initial statement of ownershipJan 26, 2024Insider tradeSEC
3 · Initial statement of ownershipJan 26, 2024Insider tradeSEC
CERT · Exchange's certificate of listingJan 26, 2024Other filingsSEC
8-A12B · Registration of shares for listing on an exchangeJan 26, 2024Other filingsSEC
253G2Jan 26, 2024Other filingsSEC
QUALIFJan 26, 2024Other filingsSEC
1-A POSJan 19, 2024Other filingsSEC
253G2Jan 11, 2024Other filingsSEC
1-SAJan 9, 2024Other filingsSEC
253G2Oct 16, 2023Other filingsSEC
QUALIFOct 2, 2023Other filingsSEC
1-A/ASep 29, 2023Other filingsSEC
CORRESP · Letter to the SECSep 15, 2023Other filingsSEC
1-A/ASep 15, 2023Other filingsSEC
UPLOAD · Letter from the SECSep 6, 2023Other filingsSEC
CORRESP · Letter to the SECAug 21, 2023Other filingsSEC
1-A/AAug 21, 2023Other filingsSEC
UPLOAD · Letter from the SECAug 3, 2023Other filingsSEC
1-AJul 6, 2023Other filingsSEC
DJun 1, 2023Other filingsSEC
DMar 20, 2023Other filingsSEC
DApr 6, 2022Other filingsSEC
DSep 3, 2014Other filingsSEC

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Autonomix Medical, Inc.’s releases · as of Nov 6, 2026

Common shares
2,045,193
Fully diluted
3,578,289

Fully diluted

LineSharesAs of
Common shares2,045,193Nov 6, 2026
Warrants1,533,096Nov 25, 2024

Warrants and options

Lot
Warrants · US$6.54 · expire about Nov 2029

Share count over time

CountShares
Nov 6, 20262,045,193

Open Cap table

Shareholders

HolderSharesOf the companyValueAs of
Fidelity Extended Market Index Fund172K8.4%US$68,730May 31, 2026
Fidelity Total Market Index Fund1,0350.05%US$414May 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Bradley Hauser
Other companies: SkinHealth Systems Inc. (Chief Operating Officer · Apr 19, 2023 – Nov 29, 2023 · Past); Soliton Inc (CEO and President, Director · Feb 19, 2019 – Dec 16, 2021 · Past); Zeltiq Aesthetics Inc (SVP, Research and Development · Jan 8, 2016 – Apr 28, 2017 · Past)
CEO and President · Since at least Jun 17, 2024
Jonathan P. Foster
Other companies: Empery Digital Inc. (Director · Since at least Jul 17, 2025); Moleculin Biotech, Inc. (Chief Financial Officer · Since at least Dec 26, 2023)
Director · Since at least Jan 26, 2024
Walter V. Klemp
Other companies: Moleculin Biotech, Inc. (Chairman, President and Chief Executive Officer · Since at least Jun 2, 2016); Soliton Inc (Executive Chairman, Director · Feb 19, 2019 – Dec 16, 2021 · Past)
Executive Chairman · Since at least Jan 26, 2024
Christopher Capelli
Other companies: Soliton Inc (CSO and Vice Chairman, Director · Feb 19, 2019 – Dec 16, 2021 · Past)
Director · Since at least Jan 26, 2024
Lori Bisson
Other companies: Soliton Inc (Chief Financial Officer · Feb 19, 2019 – Dec 16, 2021 · Past)
Executive Vice Chairman · Since at least Jan 26, 2024
Trent Smith
Other companies: InfuSystems Holdings, Inc. (Exec VP,CAO & Corp Controller · Aug 11, 2016 – Sep 7, 2017 · Past)
Chief Financial Officer · Since at least Jan 26, 2024
Brad HauserPresident and Chief Executive Officer · Since at least Sep 8, 2026
David RobinsDirector · Since at least Jan 26, 2024
Jennifer CookChief Business Officer · Since at least Nov 5, 2026
Robert SchwartzChief Medical Officer · Since at least Sep 1, 2026
All 11 people
PersonSeat
Sandra Cohen KalterDirector · Since at least Sep 16, 2026

Open People

Log in to ask 6ix AI your own questions about Autonomix Medical, Inc.